However, basic research on thyroid nodules represents just a small portion of the medical literature on tumor markers such as BRAF (V600E) mutations, RET-PTC, and RAS (21), whose sensitivity and specificity are still insufficient (28). This evidence concerns the gene BRAF and thyroid nodule.